Tunisian Patients Confront High Drug Costs
Thousands of patients in Tunisia faced difficulties affording medications as the decision to review the prices of around 300 drugs came into effect, leading to higher bills. Authorities are striving to save the pharmaceutical system and ensure market supply, but critics argue that these price hikes shift the burden of the financial crisis onto citizens, especially since the Central Pharmacy is suffering from financial problems and reduced liquidity. The crisis calls for deep structural reforms to ensure sustainable funding and guarantee the right to healthcare, with trade unions warning that the increases are insufficient to cover supply costs and advocating for the economic and health rights of patients.
Notice: This Is an AI-Generated Summary
Comments (0)